Navigation Links
ISPE Announces Nancy Berg as New CEO and President Succeeding Bob Best Effective 1 January
Date:1/3/2012

TAMPA, Fla., Jan. 3, 2012 /PRNewswire/ -- ISPE, the International Society for Pharmaceutical Engineering, today announced the appointment of Nancy S. Berg as president and CEO, effective 1 January 2012.

Berg brings 30 years of experience in strategic leadership, organizational growth and relationship-building, having served as executive director/CEO of the Society of Manufacturing Engineers (SME) and, most recently, as the founder and owner of three small businesses and consultant to both non-profits and for-profits.

At the helm of SME, Berg led the development of SME's strategic plan, Plan 2010, and the expansion of its technical networks. Through these and other forward-thinking initiatives, she prepared the organization for changes in industry business models, competitive forces and the impact of globalization.

Berg's selection by the SME Board of Directors as executive director in 2000 made her the youngest person to head a global engineering/technical organization at the time. Prior to that, she held other domestic and international positions where she gained experience that will also benefit ISPE. For example, she facilitated dialog, joint ventures and coalitions with other trade groups, associations, companies, governments and agencies. She brings to ISPE these relationship-building skills and links to industries and associations.

"Berg's demonstrated ability to anticipate industry changes, set a vision for success, then lead coordinated, dynamic efforts to achieve this plan make her the ideal person to drive us in achieving our mission," said 2012 ISPE Board Chairman Arthur "Randy" Perez. 

"As the voice of pharmaceutical engineering and manufacturing communities, ISPE is dedicated to working with Members and their companies to resolve issues and drive their understanding and use of next-generation manufacturing practices," continued Perez. "Berg's appointment comes at a time when the global pharmaceutical industry faces increased pressure to improve productivity and control costs across their product development and manufacturing operations. She brings the right blend of knowledge and leadership experience to guide us in enhancing our value to our Members, our relevance to the industry, and our role as a catalyst for solutions that will positively influence global health."

Berg replaces Bob Best, who resigned his position effective Dec. 31 after a 27-year career with the Society. Best will remain involved in the organization as a consultant through the end of 2012.

Contact:
Karen Manardo
Manardo Communications, LLC
Tel: +1-313-671-1085
kmanardo@yahoo.com


'/>"/>
SOURCE ISPE
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... -- Eli Lilly and Company (NYSE: LLY ) ... updated financial guidance for 2016 on Thursday, December 15, ... that day with the investment community and media to ... conference call will begin at 10 a.m. ET. Investors, ... webcast of the conference call through a link that ...
(Date:12/2/2016)... , December 2, 2016 Orthopedic ... & Support) is Expected to Gain a Significant Market Share ... Orthopedic Ailments  ... , According to a ... on Medical Implants Sterile Packaging: Clamshell Product Type Segment Projected ...
(Date:12/2/2016)... Research and Markets has announced the addition of ... Markets and Companies" to their offering. ... , , ... The market value of drug delivery technologies and the anticancer drugs ... according to organs involved and the types of cancer as well ...
Breaking Medicine Technology:
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... ... ... With the number of pain management programs available for people suffering with ... that works for them. When an inventor from Suisun City, Calif., was unsuccessful in ... share it with others. , He developed a prototype for PRO GO MASSAGE to ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. Raffi ... be included in the 2016 “Guide to America’s Top Plastic Surgeons” for seven ... amalgamation of their education, experience, and professional associations. , One the most ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is proud to announce ... covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping patients ... life 6 years in the last 3 decades,” says Dr. Valentine Fuster, a ...
(Date:12/2/2016)... Honolulu, Hawaii (PRWEB) , ... December 02, 2016 ... ... 3, 2016 at the Hyatt Regency Waikiki Beach Resort and Spa in Honolulu, ... (CME) in the field of pain management. , The demand for supplemental ...
Breaking Medicine News(10 mins):